Fortis Healthcare Share Price

Conference Call with Fortis Healthcare Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

• Trendlyne
• 1 week ago

Healthcare Facilities company Fortis Healthcare announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from Operations: For Q4FY26, the revenue stood at Rs 2,36,467 lakh, reflecting a YoY growth of 17.8% from Rs 2,00,720 lakh in Q4FY25, and a QoQ increase of 4.4% from Rs 2,26,501 lakh in Q3FY26. Annual revenue for FY26 was Rs 9,12,784 lakh, marking a 17.3% YoY growth compared to Rs 7,78,275 lakh in FY25. Total Income: Total income for Q4FY26 was Rs 2,36,906 lakh, up 16.9% YoY against Rs 2,02,700 lakh in Q4FY25, and an increase of 4.2% QoQ from Rs 2,27,330 lakh in Q3FY26. The total income for FY26 reached Rs 9,17,850 lakh, up 16.9% YoY from Rs 7,84,969 lakh in FY25. EBITDA: Q4FY26 EBITDA grew by 17.9% YoY to Rs 53,672 lakh from Rs 45,527 lakh in Q4FY25, and increased 4.4% QoQ from Rs 51,394 lakh in Q3FY26. Annual EBITDA for FY26 stood at Rs 2,13,564 lakh, up 29.0% YoY from Rs 1,65,488 lakh in FY25. Net Profit: Net profit for the period (from continuing operations) in Q4FY26 was Rs 27,119 lakh, showing a strong YoY growth of 44.2% from Rs 18,802 lakh in Q4FY25, and a 37.4% QoQ increase from Rs 19,740 lakh in Q3FY26. For FY26, the net profit stood at Rs 1,06,419 lakh, representing an increase of 31.5% YoY compared to Rs 80,938 lakh in FY25. Standalone Financial Highlights: Revenue from Operations: Q4FY26 revenue was Rs 46,073 lakh, registering a YoY increase of 18.6% from Rs 38,847 lakh in Q4FY25, and a QoQ growth of 4.0% from Rs 44,293 lakh in Q3FY26. Annual revenue for FY26 grew by 24.0% YoY to Rs 1,79,250 lakh from Rs 1,44,589 lakh in FY25. Total Income: Total income for Q4FY26 stood at Rs 47,726 lakh, up 15.4% YoY against Rs 41,346 lakh in Q4FY25, and up 3.9% QoQ from Rs 45,915 lakh in Q3FY26. For FY26, total income was Rs 1,95,768 lakh, up 19.0% YoY from Rs 1,64,444 lakh in FY25. EBITDA: Q4FY26 EBITDA surged 32.2% YoY to Rs 12,684 lakh from Rs 9,595 lakh in Q4FY25, and increased 10.3% QoQ from Rs 11,498 lakh in Q3FY26. Annual EBITDA for FY26 stood at Rs 56,224 lakh, up 23.8% YoY from Rs 45,406 lakh in FY25. Net Profit: Net profit for Q4FY26 stood at Rs 2,498 lakh, recovering from a net loss of Rs 4,223 lakh in Q4FY25, while it saw a decline of 12.0% QoQ from Rs 2,840 lakh in Q3FY26. Annual net profit for FY26 stood at Rs 23,034 lakh, reflecting an exceptional 261.1% YoY growth from Rs 6,379 lakh in FY25. Business Highlights: Healthcare Segment: For Q4FY26, the healthcare segment's revenue from operations was Rs 2,02,323 lakh, up 18.9% YoY and 4.4% QoQ. Segment profit for Q4FY26 grew 18.1% YoY and 7.5% QoQ to Rs 35,475 lakh. Full-year FY26 revenue reached Rs 7,77,269 lakh (up 19.1% YoY), while the annual segment profit stood at Rs 1,39,370 lakh (up 30.2% YoY). Diagnostics Segment: Q4FY26 revenue from operations was Rs 38,726 lakh, marking an 11.1% YoY and 4.4% QoQ growth. Segment profit for Q4FY26 surged 69.2% YoY to Rs 5,561 lakh, while staying largely flat sequentially (up 0.2% QoQ). Annual FY26 revenue grew by 8.5% YoY to Rs 1,52,656 lakh, and annual segment profit witnessed an 83.9% YoY jump to Rs 24,185 lakh. Corporate & Strategic Updates: Dividend: The Board of Directors recommended a final dividend of Rs 1 per equity share (10% of face value of Rs 10 each) for the financial year 2025-26. Acquisitions: On January 09, 2026, the Company’s wholly-owned subsidiary, International Hospital Limited (IHL), consummated the acquisition of TMI Healthcare Private Limited (TMI), which runs the 125-bedded 'People Tree Hospital' in Bengaluru, along with its building and land, for a cumulative transaction value of Rs 43,386 lakh. Fortis Hospotel Limited (FHTL) successfully acquired the entire business operations of Shrimann Superspecialty Hospital situated in Jalandhar for an overall consideration of Rs 46,190 lakh. Brand & Trademark Milestones: Agilus Diagnostics Limited (formerly SRL Limited) successfully secured the 'SRL' brand and allied trademarks as the highest bidder by placing a bid of Rs 8 crore in a public auction, receiving a "Certificate of Sale" from the Delhi High Court. Fortis Healthcare successfully acquired the 'Fortis' brand and allied trademarks as the highest bidder in a public auction for a total bid price of Rs 20,000 lakh. Mergers and Re-structuring: The Composite Scheme of Amalgamation of Fortis Emergency Services Limited, Birdie & Birdie Realtors Private Limited, Fortis Health Management (East) Limited and Fortis Cancer Care Limited with Fortis Hospitals Limited (FHsL) received NCLT approvals and became effective from March 01, 2026. Operations & Maintenance (O&M;): The Company entered into an O&M; Services agreement with Gleneagles Healthcare India Private Limited to manage the operations of five hospitals and one clinic, effective July 23, 2025. Open Offers: The Fortis Open Offer and Malar Open Offer initiated by the Acquirer (Northern TK Venture Pte Ltd / IHH Healthcare Berhad) were successfully completed on November 10, 2025. Labour Code Impact: The new Government of India Labour Codes resulted in a one-time provision increase for employee benefits amounting to Rs 5,518 lakh, which was recognized as an 'Exceptional Item' in the FY26 consolidated financial statements. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, said: “We have witnessed a steady business performance in Q4 enabling us to end the year on a healthy note. Our hospital business, which now contributes 85% to our overall revenues continues to do well. We have maintained our investment momentum in augmenting medical equipment and technology, adding to our clinical depth and expanding key medical programs. For FY26, our top 6 specialties have grown 19% notably amongst them being Renal Sciences and Orthopedics, which witnessed a growth of 22% and 21%, respectively.” “I’m also pleased to share that the year gone by has seen network expansion in our key geographies through brownfield initiatives and acquisitions. As part of our inorganic growth strategy, we added ~500 beds to our network through the acquisition of People Tree Hospital, Bengaluru; the Shrimann Hospital in Jalandhar, Punjab and with a long-term lease arrangement for the Greater Noida Hospital in Delhi NCR. We continue to progress on our brownfield expansion plans and actively evaluate further inorganic growth opportunities within our focus geographic clusters.” Result PDF

• Trendlyne
• 1 week ago

IHH Healthcare eyes aggressive India expansion via Fortis, focusing on bed capacity, clusters, and ambulatory care amid strong healthcare demand

• Business Standard
• 1 month 3 weeks ago